Publication | Closed Access

An Open-Label, Phase I, Dose-Escalation Study of Tumor Necrosis Factor-α (TNFerade™ Biologic) Gene Transfer with Radiation Therapy for Locally Advanced, Recurrent, or Metastatic Solid Tumors

Radiation MedicineRadiation TherapyMedicinePathologyTnferade™ BiologicCancer TreatmentOncologyRadiation OncologyTumor Necrosis Factor-αGene Transfer